Q32 Bio (DB0) Q3 2026 Earnings Report

2 Followers

DE:DB0 Q3 2026 EPS Results

Actual EPS: -EUR 0.23
Consensus EPS: -EUR 0.29
Beat/Miss: Beat by +EUR 0.06
One Year Ago EPS: -EUR 0.53

DE:DB0 Q3 2026 Revenue Results

Actual Revenue: EUR 0
Expected Revenue: EUR 0
Beat/Miss: Met expectations
YoY Revenue Growth: ―

Earnings Announcement Details

Quarter: Q3 2026
Date: 11/04/2026
Time: Before Open
Conference Call: Wednesday, November 4, 2026

DE:DB0 Upcoming Earnings

Q32 Bio's next earnings date is estimated for March 16, 2027, based on past reporting schedules.

Q3 2026 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q3 2026 Earnings Slide Deck

No slide deck is available for this earnings event.

Q3 2026 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:DB0 Earnings History

DE:DB0 earnings history
Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Press Release
Mar 16, 2027	2026 (Q4)	-0.25-	4.07	―	―
Nov 04, 2026	2026 (Q3)	-0.29-0.23	-0.53	56.67% (+0.30)
Aug 05, 2026	2026 (Q2)	-0.48-0.39	-0.69	43.59% (+0.30)
May 05, 2026	2026 (Q1)	-0.60-0.48	-0.8	40.00% (+0.32)
Mar 10, 2026	2025 (Q4)	-0.764.07	-1.03	494.83% (+5.10)
Nov 13, 2025	2025 (Q3)	-1.06-0.53	-1.3	58.90% (+0.76)
Aug 06, 2025	2025 (Q2)	-0.87-0.69	-1.26	45.07% (+0.57)
May 08, 2025	2025 (Q1)	-1.09-0.80	-5.62	85.78% (+4.82)
Mar 11, 2025	2024 (Q4)	-1.36-1.03	-2.94	64.95% (+1.91)
Nov 07, 2024	2024 (Q3)	-1.23-1.30	-9.12	85.77% (+7.82)
Aug 08, 2024	2024 (Q2)	-0.89-1.26	-9.76	87.07% (+8.49)
May 09, 2024	2024 (Q1)	-1.26-5.62	-8	29.67% (+2.37)
Mar 13, 2024	2023 (Q4)	-4.80-4.44	-9.6	53.69% (+5.15)
Nov 14, 2023	2023 (Q3)	-6.72-9.12	-9.44	3.39% (+0.32)
Aug 14, 2023	2023 (Q2)	-7.56-9.76	-8.16	-19.61% (-1.60)
May 11, 2023	2023 (Q1)	-8.48-8.00	25.43	-131.45% (-33.43)
Mar 09, 2023	2022 (Q4)	-7.87-9.60	-9.44	-1.69% (-0.16)
Nov 10, 2022	2022 (Q3)	-7.30-9.44	-8.64	-9.26% (-0.80)
Aug 15, 2022	2022 (Q2)	-8.60-8.16	-8.64	5.56% (+0.48)
May 16, 2022	2022 (Q1)	-7.8825.43	-0.32	8050.00% (+25.75)
Mar 23, 2022	2021 (Q4)	-9.19-9.44	-9.92	4.84% (+0.48)
Nov 15, 2021	2021 (Q3)	-9.39-8.64	-9.92	12.90% (+1.28)
Aug 12, 2021	2021 (Q2)	-9.20-8.64	-12.48	30.77% (+3.84)
May 06, 2021	2021 (Q1)	―-0.32	-12.48	97.44% (+12.16)
Mar 11, 2021	2020 (Q4)	-10.54-9.92	-8.8	-12.73% (-1.12)
Nov 09, 2020	2020 (Q3)	-12.94-9.92	-10.72	7.46% (+0.80)
Aug 10, 2020	2020 (Q2)	-11.84-12.48	-9.76	-27.87% (-2.72)
May 07, 2020	2020 (Q1)	-11.04-12.48	-10.24	-21.88% (-2.24)
Mar 12, 2020	2019 (Q4)	―-0.49	-0.45	-7.84% (-0.04)
Nov 12, 2019	2019 (Q3)	―-0.60	-0.36	-67.50% (-0.24)
Aug 08, 2019	2019 (Q2)	―-0.54	-0.31	-74.29% (-0.23)
May 13, 2019	2019 (Q1)	―-0.57	-3.74	84.80% (+3.17)
Mar 12, 2019	2018 (Q4)	―-0.45	-0.28	-60.38% (-0.17)
Nov 13, 2018	2018 (Q3)	―-0.36	-0.15	-129.89% (-0.20)
Aug 13, 2018	2018 (Q2)	―-0.31	―	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed

Q32 Bio earnings date